Intellia Therapeutics
Price & Volume
Stats
See moreOpen | $9.97 |
Previous Close | $10.01 |
Day Range | $9.95-$10.20 |
52W Range | $9.25-$34.87 |
Market Cap | $1B |
Shares Short | 24M |
Financials
See moreRevenue (12 Mos) | $43M |
Revenue Growth (YoY) | -24% |
Gross Profit (12 Mos) | -$415.3M |
Diluted EPS | -$5.45 |
News
See moreYahoo Finance • 8 days ago
Intellia Therapeutics Announces First Patient Dosed in the HAELO Phase 3 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema
Yahoo Finance • 3 months ago
Intellia Therapeutics, Inc. (NTLA) the Most Promising Biotech Stock According to Hedge Funds?
Yahoo Finance • 4 months ago
2 Cathie Wood Stocks That Could Soar 32% and 282%, According to Wall Street
Yahoo Finance • 6 months ago
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
About
CEO | Dr. John M. Leonard M.D. |
Address | 40 Erie Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 526 |
